4 research outputs found
Abuse potential assessment of propofol by its subjective effects after sedation
Tezcan, Aysu Hayriye/0000-0001-7779-6965; Ornek, Dilsen/0000-0002-3300-4839WOS: 000346112400015PubMed: 25674117Objective: In this study, we examined the euphoric effect of propofol and its high satisfaction ratio regarding its liability to be abused, particularly in painless procedures, such as colonoscopy. Methods: Fifty subjects aged between 18 and 65 years who fulfilled the criteria for ASA 1-2 and were prepared for colonoscopy were enrolled into this study. For intravenous sedation induction, 2 mg/kg propofol was used, and additional injections were administered according to BIS values. After colonoscopy, the subjects were taken to a recovery room and observed for 30 minutes. Patients were interviewed with the modified Brice questionnare regarding the incidence and the content of dreams. A 5-point Likert scale was used to classify their dreams, and the content of the dreams was also recorded. To assess the subjective effects of propofol, the patients were asked to use the Hall and Van der Castle emotion scale; their biological states were also assessed. The patients' feelings regarding propofol were each rated as absent or present. We used the Morphine-Benzedrine Group scale to measure the euphoric effects of propofol. At the end of the study, subjects scored their satisfaction on a five-point scale. Results: There were no statistically significant differences in sex age, weight, propofol dose, or satisfaction ratio (p > 0.05) in the groups, although male patients received a higher dose of propofol and had higher satisfaction ratio. Patients reported no residual after-effects. The incidence of dreaming was 42%. There was no statistically significant difference in dreaming between the sexes, but male patients had a higher dreaming ratio. Dreamers received higher propofol doses and had a higher satisfaction ratio (p > 0.05). All dreamers reported happy dreams regarding daily life, and their mean MBG score was 10.5. There was no correlation between MBG scores and propofol doses (r = -0.044, p = 0.761). Conclusions: We conclude that propofol functions as a reward; that patients enjoy its acute effects; and that no residual after-effects should arise. We suggest that propofol may carry potential for abuse, and further abuse liability testing is indicated
The Effect of Systemic and Regional Use of Magnesium Sulfate on Postoperative Tramadol Consumption in Lumbar Disc Surgery.
To investigate the effect of magnesium administered to the operative region muscle and administered systemically on postoperative analgesia consumption after lumbar disc surgery
The Effect of Systemic and Regional Use of Magnesium Sulfate on Postoperative Tramadol Consumption in Lumbar Disc Surgery
Aim. To investigate the effect of magnesium administered to the operative region muscle and administered systemically on postoperative analgesia consumption after lumbar disc surgery. Material and Method. The study included a total of 75 ASA I-II patients aged 18–65 years. The patients were randomly allocated into 1 of 3 groups of 25: the Intravenous (IV) Group, the Intramuscular (IM) Group, and the Control (C) Group. At the stage of suturing the surgical incision site, the IV Group received 50 mg/kg MgSO4 intravenously in 150 mL saline within 30 mins. In the IM Group, 50 mg/kg MgSO4 in 30 mL saline was injected intramuscularly into the paraspinal muscles. In Group C, 30 mL saline was injected intramuscularly into the paraspinal muscles. After operation patients in all 3 groups were given 100 mg tramadol and 10 mg metoclopramide and tramadol solution was started intravenously through a patient-controlled analgesia device. Hemodynamic changes, demographic data, duration of anesthesia and surgery, pain scores (NRS), the Ramsay sedation score (RSS), the amount of analgesia consumed, nausea- vomiting, and potential side effects were recorded. Results. No difference was observed between the groups. Nausea and vomiting side effects occurred at a rate of 36% in Group C, which was a significantly higher rate compared to the other groups (p<0.05). Tramadol consumption in the IM Group was found to be significantly lower than in the other groups (p<0.05). Conclusion. Magnesium applied to the operative region was found to be more effective on postoperative analgesia than systemically administered magnesium
The Effect of Systemic and Regional Use of Magnesium Sulfate on Postoperative Tramadol Consumption in Lumbar Disc Surgery
Aim. To investigate the effect of magnesium administered to the
operative region muscle and administered systemically on postoperative
analgesia consumption after lumbar disc surgery. Material and Method.
The study included a total of 75 ASA I-II patients aged 18-65 years. The
patients were randomly allocated into 1 of 3 groups of 25: the
Intravenous (IV) Group, the Intramuscular (IM) Group, and the Control
(C) Group. At the stage of suturing the surgical incision site, the IV
Group received 50mg/kg MgSO4 intravenously in 150 mL saline within 30
mins. In the IM Group, 50mg/kg MgSO4 in 30 mL saline was injected
intramuscularly into the paraspinal muscles. In Group C, 30 mL saline
was injected intramuscularly into the paraspinal muscles. After
operation patients in all 3 groups were given 100 mg tramadol and 10 mg
metoclopramide and tramadol solution was started intravenously through a
patient-controlled analgesia device. Hemodynamic changes, demographic
data, duration of anesthesia and surgery, pain scores (NRS), the Ramsay
sedation score (RSS), the amount of analgesia consumed, nausea-vomiting,
and potential side effects were recorded. Results. No difference was
observed between the groups. Nausea and vomiting side effects occurred
at a rate of 36\% in Group C, which was a significantly higher rate
compared to the other groups (p < 0.05). Tramadol consumption in the IM
Group was found to be significantly lower than in the other groups (p <
0.05). Conclusion. Magnesium applied to the operative region was found
to be more effective on postoperative analgesia than systemically
administered magnesium